Julie Parsons, MD
Julie Parsons, MD, is a professor of clinical pediatrics and neurology and co-director of the Neuromuscular Clinic at Children’s Hospital Colorado
Articles
Describing SMA Progression Over Time
Panelists discuss how spinal muscular atrophy (SMA) progresses over time, affecting motor function differently in older patients vs infants, with experts noting the shift from traditional classification (types 1 to 4) to functional categories (nonsitters, sitters, walkers).
Key Considerations for Choosing the Right SMA Treatment
FDA-approved treatments for spinal muscular atrophy differ in their mechanisms of action, safety profiles, and administration challenges, with key selection factors like patient age and gene copy number, according to Julie Parsons, MD, a professor and neurologist from the University of Colorado School of Medicine.
